Dynamic Advisor Solutions LLC bought a new position in shares of Aflac Incorporated (NYSE:AFL – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,852 shares of the financial services provider’s stock, valued at approximately $206,000.
Other hedge funds also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC acquired a new stake in Aflac during the 4th quarter worth approximately $26,000. BankPlus Trust Department acquired a new stake in Aflac during the 4th quarter worth approximately $34,000. Curio Wealth LLC acquired a new stake in Aflac during the 4th quarter worth approximately $36,000. Capital A Wealth Management LLC acquired a new stake in Aflac during the 4th quarter worth approximately $38,000. Finally, OFI Invest Asset Management acquired a new stake in Aflac during the 4th quarter worth approximately $38,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Aflac Price Performance
Shares of AFL opened at $103.31 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09. Aflac Incorporated has a 1-year low of $88.00 and a 1-year high of $115.50. The stock has a market cap of $55.85 billion, a PE ratio of 16.14, a price-to-earnings-growth ratio of 3.18 and a beta of 0.82. The firm has a fifty day moving average price of $104.91 and a 200 day moving average price of $105.27.
Aflac Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were given a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a yield of 2.25%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac’s dividend payout ratio (DPR) is 36.25%.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on AFL shares. Morgan Stanley increased their target price on shares of Aflac from $100.00 to $105.00 and gave the stock an “equal weight” rating in a report on Monday, May 19th. Wall Street Zen lowered shares of Aflac from a “hold” rating to a “sell” rating in a report on Monday, May 5th. UBS Group increased their target price on shares of Aflac from $109.00 to $114.00 and gave the stock a “neutral” rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. raised their price objective on shares of Aflac from $94.00 to $96.00 and gave the company a “neutral” rating in a report on Wednesday, April 2nd. Finally, Barclays boosted their target price on shares of Aflac from $95.00 to $96.00 and gave the stock an “underweight” rating in a research note on Thursday, May 1st. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Aflac presently has a consensus rating of “Hold” and an average target price of $104.93.
View Our Latest Report on Aflac
Insiders Place Their Bets
In other Aflac news, Director Arthur Reginald Collins sold 2,750 shares of Aflac stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the transaction, the director now directly owns 6,728 shares in the company, valued at approximately $711,149.60. The trade was a 29.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Masatoshi Koide sold 37,000 shares of Aflac stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the transaction, the director now owns 70,992 shares in the company, valued at approximately $7,496,045.28. This represents a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 40,750 shares of company stock valued at $4,304,295 over the last quarter. Company insiders own 0.90% of the company’s stock.
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- How to Invest in Insurance Companies: A GuideĀ
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- How to Read Stock Charts for Beginners
- Overheated Market? Analysts Watch These Red Flags
- What Are Dividend Achievers? An Introduction
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.